How does a fractional Chief Revenue Officer build pipeline for a life sciences company?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

How to Build Pipeline for a Life Sciences Company

Fractional CRO vs. Full-Time CRO

Why Life Sciences Pipeline Building Is Different

Life sciences sales cycles are not like SaaS. A buyer in diagnostics or therapeutics faces regulatory hurdles, budget cycles tied to grants or institutional approvals, and a high number of stakeholders - often including a principal investigator, a lab manager, a compliance officer, and a procurement team. In 2027, the market has shifted: many buyers now expect virtual demos and asynchronous engagement before any in-person meeting. A fractional CRO must adapt to this by using account-based marketing (ABM) tactics combined with regulatory intelligence (e.g., tracking FDA approvals or clinical trial updates relevant to your product).

The fractional CRO will not "hunt" in the traditional sense. Instead, they will engineer a pipeline by:

• Mapping the buyer journey for your specific vertical. For example, a diagnostic company selling to hospital labs needs to understand the CAP/CLIA accreditation process and how that affects procurement.
• Leveraging partnerships with key opinion leaders (KOLs) or conference organizers to generate warm introductions. This is often more effective than cold outreach in life sciences.
• Using data enrichment tools to identify labs or institutions that recently received new funding or published relevant research. Tools like ZoomInfo or Lusha can help, but the fractional CRO will focus on signal-based selling (e.g., a lab hiring a new director is a strong buying signal).

The Role of Revenue Operations in Pipeline Generation

A fractional CRO cannot build pipeline alone. They must install a revenue operations (RevOps) function - even if it's a part-time analyst or a HubSpot/Salesforce admin. In 2027, the best fractional CROs treat RevOps as the backbone of pipeline generation. This means:

• Cleaning your CRM of duplicates and outdated contacts. A common problem in life sciences is that CRM data rots quickly because of lab staff turnover.
• Setting up lead scoring that weights regulatory milestones (e.g., "Company received FDA 510(k) clearance" or "Published in Nature") higher than generic web visits.
• Creating a dashboard that tracks pipeline velocity by stage, not just volume. The fractional CRO will monitor how long deals sit in "technical evaluation" and intervene with targeted content (e.g., a validation study white paper).

The fractional CRO will also train your existing team on pipeline hygiene. If you have a salesperson who logs every email manually, they'll automate it with Outreach or Salesloft sequences. If your team avoids CRM updates, the fractional CRO will implement a weekly pipeline review where each rep explains their top 5 deals.

How a Fractional CRO Balances Strategy and Execution

One of the most common fears founders have is that a fractional CRO will be "too strategic" and never pick up the phone. In life sciences, that fear is valid - but the best fractional CROs do both. They will:

• Write the playbook (strategy) and train the team (execution).
• Join key sales calls with top prospects to model effective discovery questions.
• Negotiate pricing and contracts for the first 3-5 deals to set a precedent.
• Build a referral program with existing customers, which is especially powerful in life sciences because the community is small and trust-based.

The trade-off is that a fractional CRO cannot be your full-time closer. If your company needs someone to make 50 cold calls a day, hire a junior SDR instead. The fractional CRO's value is in designing the system that makes those calls effective.

When a Fractional CRO Is the Wrong Choice

Not every life sciences company should hire a fractional CRO. Consider alternatives if:

• You have no revenue at all (pre-revenue). A fractional CRO may be too expensive; consider a part-time consultant or a founder-led sales motion first.
• Your product is still in clinical trials with no clear commercial path. Pipeline building requires a product that can be sold now.
• You need a full-time manager for a growing sales team of 5+ people. Fractional leaders can manage teams, but they lack daily presence for coaching and culture building.
• You are raising a large round ($10M+) and investors expect a full-time CRO on the cap table. Some VCs view fractional roles as a sign of insufficient commitment.

Measuring Success: Pipeline Metrics That Matter

A fractional CRO should be measured on leading indicators, not just closed revenue (which can take 12+ months in life sciences). Key metrics include:

• Pipeline coverage ratio: Total pipeline value divided by your quarterly target. A healthy ratio is 3x-5x for life sciences.
• Time to first meeting: How quickly a qualified lead schedules a discovery call. Aim to reduce this from weeks to days.
• Conversion rates by stage: From MQL to SQL, SQL to opportunity, opportunity to closed-won. The fractional CRO will benchmark these against industry norms (not invented here - use your own historical data).
• Sales cycle length: Tracked in days/weeks. A fractional CRO should shorten this by removing bottlenecks (e.g., slow technical validation).

The Life Sciences Buyer: What Has Changed

By 2027, the life sciences buyer has become more digitally savvy but also more skeptical of sales outreach. They have been bombarded by AI-generated emails and generic LinkedIn messages. A fractional CRO must cut through the noise by:

• Using personalized video (e.g., Loom) to explain how your product solves a specific regulatory pain point.
• Leveraging peer reviews from platforms like G2 or MedTech reviews. Buyers now check these before taking a meeting.
• Hosting virtual roundtables with KOLs rather than cold outreach. This builds credibility and generates warm leads.

The fractional CRO will also automate the low-value parts of pipeline generation. For example, they might use a chatbot on your website to qualify visitors from academic institutions, then route them to a sales rep only if they match the ICP.

How to Evaluate a Fractional CRO for Life Sciences

When interviewing a fractional CRO, ask these specific questions:

1. "What life sciences companies have you worked with?" Look for experience in your sub-vertical (diagnostics, therapeutics, devices, digital health). General SaaS experience is not enough.
2. "How do you handle regulatory objections?" They should be able to discuss FDA 510(k), CE marking, CLIA, or HIPAA implications for sales.
3. "What is your process for building a pipeline from zero?" They should describe a step-by-step audit, ICP definition, and outreach sequence, not vague "networking."
4. "Can you provide references from life sciences clients?" Call those references and ask about pipeline velocity improvements, not just closed revenue.
5. "What tools do you recommend?" They should name specific tools (Salesforce, HubSpot, Gong, Clari, Outreach) and explain why, without making quantified claims.

FAQ

How long does it take a fractional CRO to build pipeline in life sciences? Typically 60-90 days to see the first qualified meetings, assuming you have a product that is ready to sell. The first 30 days are spent on audit and strategy; the next 30-60 days on execution.

Can a fractional CRO sell to hospitals or large institutions? Yes, but only if they have experience with hospital procurement cycles (e.g., GPO contracts, value analysis committees). Ask specifically about this during interviews.

What if my life sciences company is pre-revenue? Should I still hire a fractional CRO? Probably not. Focus on founder-led sales or a part-time consultant for $3k-$5k/month to validate product-market fit first. A fractional CRO is most valuable when you have some revenue and need to scale.

Do fractional CROs work remote or on-site? Most work remote, especially for life sciences companies outside major hubs. However, they should be willing to travel for key conferences (e.g., J.P. Morgan Healthcare Conference, BIO) and customer meetings.

Related on PULSE

• [Is there a fractional CRO available near me in Pasadena in 2027?](/knowledge/tl12271)
• [Who is the best fractional Chief Revenue Officer in Middletown in 2027?](/knowledge/tl20960)
• [What should an SMB company look for in a fractional CRO in 2027?](/knowledge/tl11523)
• [Is there a fractional CRO available near me in Boise in 2027?](/knowledge/tl11886)
• [Is there a fractional CRO available near me in Massachusetts in 2027?](/knowledge/tl12062)
• [Is there a fractional Chief Revenue Officer available near me in Detroit in 2027?](/knowledge/tl16754)

Sources

• Pavilion - Revenue Leadership Community
• RevOps Co-op - Revenue Operations Resources
• Harvard Business Review - Sales Strategy
• First Round Review - Go-to-Market Advice
• SaaStr - B2B Sales and Revenue
• LinkedIn - Revenue Leadership Groups

People also search for: fractional chief revenue officer life sciences company · hire a fractional chief revenue officer for life sciences company · life sciences company fractional chief revenue officer · fractional chief revenue officer near me